Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older

Full article: Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study

Microorganisms, Free Full-Text

Full article: Real-world impact and effectiveness of MenACWY-TT

Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence

Frontiers Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco

An evaluation of emerging vaccines for childhood meningococcal disease – topic of research paper in Economics and business. Download scholarly article PDF and read for free on CyberLeninka open science hub.

Full article: Real-world impact and effectiveness of MenACWY-TT

Full article: Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States

PDF) Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older

Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older

Frontiers Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco